Zevra Therapeutics, Inc. ZVRA Net Investment in Lease
Net Investment in Lease at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zevra Therapeutics, Inc.'s net investment in lease.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Zevra Therapeutics, Inc.'s net investment in lease?
- Zevra Therapeutics, Inc. (ZVRA) reported net investment in lease of $1.09M in Q1 2026.
- How has Zevra Therapeutics, Inc.'s net investment in lease changed year-over-year?
- Zevra Therapeutics, Inc.'s net investment in lease decreased by 33.6% year-over-year, from $1.64M to $1.09M.
- What is the long-term trend for Zevra Therapeutics, Inc.'s net investment in lease?
- Over 5 years (2020 to 2025), Zevra Therapeutics, Inc.'s net investment in lease has grown at a -2.1% compound annual growth rate (CAGR), from $1.35M to $1.21M.